Services
Market access and reimbursement for pharma, MedTech and digital health
For market access and executive leads in pharma, MedTech and digital health. We develop reimbursement pathways and market access strategy, define pricing, model business case scenarios and plan launch and commercialisation. As consultant or implementation partner, depending on the starting position.
45-minute initial call on Teams, no obligation.
01
Services at a glance
Strategy, reimbursement and commercialisation from a single source.
Reimbursement pathways and market access strategy
Pricing definition
Business case scenarios and growth planning
Market and positioning strategy
Regulatory classification (MDR, DiGA, AI Act)
Launch and commercialisation planning
02
Reimbursement pathways for medical software
The right pathway depends on medical purpose, target group, care context, evidence base and regulatory classification.
Hospital reimbursement via DRG, supplementary payment or NUB structures
Listing in the medical aids directory
Selective contracts with health insurers
Listing as a DiGA or DiPA
Individual care or licence models with healthcare providers
FAQ
Frequently Asked Questions
Get in touch
Schedule a no-obligation initial conversation and find out how we can concretely support your initiative.
See all services